70 PROTEIN EXPRESSION OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR DURING BOVINE PRE-IMPLANTATION EMBRYONIC DEVELOPMENT

2014 ◽  
Vol 26 (1) ◽  
pp. 149
Author(s):  
F. Poppicht ◽  
H. Stinshoff ◽  
C. Wrenzycki

Insulin-like growth factor 1 (IGF1) is essential for regulating physiological processes such as growth and development of fetal and placental tissues (Bauer et al. 1998, Fowden 2003). During early embryonic development, IGF1 plays an important role, as it leads to a reduction of apoptosis and decreases early embryonic mortality (Block et al. 2007). The signal transduction of IGF1 is carried out by its specific binding to the membrane-embedded insulin-like growth factor 1 receptor (IGF1R). The expression of IGF1R is a potential quality marker of in vitro produced embryos (Liu et al. 1997, Yaseen et al. 2001). Thus far, analysis of the relative amount of specific transcripts is the method of choice to study bovine pre-implantation embryos, as information on protein expression is scarce. Therefore, it is of great interest to analyse protein expression and to determine if and to which extent these results differ from results obtained in previous mRNA expression analyses. In the present study, a total of 4800 cumulus-oocyte-complexes were deployed in 60 in vitro produced runs. The cleavage rates averaged 57.4 ± 7.3% and blastocyst rates were 27.6 ± 7.5% at Day 8 of culture. Embryos at the blastocyst stage were frozen and stored at –80°C for further experiments. The protein expression of the IGF1R during early embryonic development was investigated by Western blot analysis testing 8 different antibodies. Seven of these antibodies were commercially available and mainly not tested in the bovine species. Only 1 of these antibodies resulted in a weak signal for the IGF1R protein in bovine blastocysts. Therefore, a specific peptide antibody against 2 peptide sequences of the α unit of the bovine IGF1R was produced. The analysis of the IGF1R protein with this antibody resulted in the determination of a signal in a pool of 100 blastocysts, which was weaker than in the positive control (20 μg of bovine liver protein extract). The detection of the IGF1R protein localization was possible in all different stages of embryonic development from the zygote to the expanded blastocyst using immunfluorescence staining with the specific peptide antibody. The IGF1R protein was mainly expressed in the plasma membrane of single blastomeres and also weakly in the cytoplasm. As the early bovine embryo expresses IGF1R throughout all stages, the main function of IGF1 in embryonic development needs to be further elucidated. We gratefully acknowledge the financial support of the H. Wilhelm Schaumann Foundation (Hamburg, Germany).

2015 ◽  
Vol 27 (1) ◽  
pp. 191 ◽  
Author(s):  
F. Poppicht ◽  
H. Stinshoff ◽  
C. Wrenzycki

Insulin-like growth factor 1 (IGF1) is a key regulator in early embryonic development, influencing physiological processes and stimulating growth and development (Fowden et al. 2003). Supplementing IGF1 during in vitro culture of bovine embryos improved cleavage and developmental rates while it reduced apoptosis (Byrne et al. 2002). The signal transduction of IGF1 is performed by its binding to the insulin-like growth factor 1 receptor (IGF1R). At the mRNA level, IGF1R is expressed throughout pre-implantation embryonic development and was identified as a potential marker of good quality embryos (Yaseen et al. 2001). However, information on protein level is rare. Therefore, protein expression of the IGF1R during early embryonic development in vitro was analysed in the present study by immunofluorescence staining. Furthermore, the mRNA expression of the IGF1R was investigated by RT-qPCR. In vitro derived embryos of different stages (2-cell, 4-cell, 8-cell, 16-cell stage, morula, blastocyst, and expanded blastocyst) were either directly subjected to immunofluorescence staining or frozen at –80°C for use in RT-qPCR. Staining was performed with a peptide antibody against two peptide sequences of the bovine IGF1R α unit, which was specifically produced. Pixel intensity of immunofluorescence was measured and a mean grey value was calculated using the cellsens® software (Olympus, Hamburg, Germany). Data were analysed by one-way ANOVA followed by a Tukey's test using SigmaStat 3.5 Software (Systat Software GmbH, Erkrath, Germany). The detection of the IGF1R mRNA and protein was possible in all stages of embryonic development beginning at the 2-cell stage up to the expanded blastocyst. The maximal mRNA expression could be observed in 2- and 4-cell embryos. It significantly decreased to the 8-cell stage, followed by an increase up to the expanded blastocyst. The IGF1R protein was mainly localised in the plasma membrane of single blastomeres and also weakly in the cytoplasm. Mean grey values are highest in the 2-cell stage, showing a significant decline up to the 16-cell stage and an increase again until the expanded blastocyst. The mRNA and protein expression showed similar patterns during early embryonic development. IGF1R expression started to increase at the 8-cell stage (mRNA) and 16-cell stage (protein) indicating a link to the maternal-embryonic transition. For the first time, these results show that in bovine embryos, the IGF1R expression is related to the activation of the embryonic genome. We gratefully acknowledge the financial support of the H. Wilhelm Schaumann Foundation (Hamburg, Germany).


2019 ◽  
Vol 21 (5) ◽  
pp. 260-269
Author(s):  
Anelise dos Santos Mendonça ◽  
Maurício Machaim Franco ◽  
José de Oliveira Carvalho ◽  
Grazieli Marinheiro Machado ◽  
Margot Alves Nunes Dode

1997 ◽  
Vol 9 (6) ◽  
pp. 571 ◽  
Author(s):  
Christopher G. Grupen ◽  
Hiroshi Nagashima ◽  
Mark B. Nottle

The effects of epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I) on the in vitro maturation of porcine oocytes were examined. Oocytes obtained from the ovaries of slaughtered prepubertal gilts were matured in modified Medium 199 supplemented with 25% porcine follicular ßuid and gonadotropins, and fertilized in vitro. Oocytes were either xed 16 h later to assess fertilization or cultured for 7 days to assess embryonic development. In Experiment 1, the addition of EGF to maturation medium increased the percentage of meiotically mature oocytes (88% v. 70%; P < 0· 001) but did not affect the proportion of fertilized or cleaved oocytes. Blastocysts derived from oocytes matured in medium supplemented with 10 ng mL-1 EGF had a greater number of cells compared with those of control blastocysts (51·1 ± 5· 1 v. 36·0 ± 3·1; P < 0· 02). In Experiment 2, the addition of IGF-I to maturation medium had no effect on meiotic maturation, fertilization or embryonic development. Our ndings demonstrate that EGF plays an important role in both the meiotic and cytoplasmic maturation of porcine oocytes in vitro.


2008 ◽  
Vol 20 (1) ◽  
pp. 135
Author(s):  
K. B. Lee ◽  
A. Bettegowda ◽  
J. J. Ireland ◽  
G. W. Smith

We have previously demonstrated a positive association of follistatin mRNA abundance with bovine oocyte competence. Furthermore, exogenous follistatin supplementation during the early stages of in vitro bovine embryo development (before embryonic genome activation) can reduce time to first cleavage, increase proportion of embryos developing to the blastocyst stage, and increase trophectoderm cell numbers, suggesting a potential role for follistatin in bovine early embryonic development. However, the requirement of endogenous follistatin for early embryogenesis in cattle has not been directly tested. Thus, the aim of the present study was to determine the requirement of follistatin for early embryonic development using small interfering RNA (siRNA)- based knockdown procedures. Small interfering RNA corresponding to exons 2 (siRNA 2) and 3 (siRNA 3) of the bovine follistatin gene were synthesized, and the optimal dose of each siRNA resulting in maximal reduction in follistatin mRNA (at the 4-cell stage) following microinjection into presumptive zygotes was determined. Injection of follistatin siRNA 2 or siRNA 3 resulted in a >80% decrease in follistatin mRNA abundance in 4-cell embryos, but mRNA abundance for 5 housekeeping genes and the oocyte-specific gene JY-1 was not affected. Effects of follistatin siRNA injection on follistatin protein abundance were evaluated by immunofluorescence staining of 16-cell embryos. Follistatin immunoreactivity was dramatically reduced in siRNA-treated v. uninjected embryos. Upon validation, the effects of follistatin siRNA on early embryonic development were investigated. Cumulus–oocyte complexes were harvested from ovaries obtained from a local abattoir, matured and fertilized in vitro. Sixteen to 18 h following fertilization, denuded presumptive zygotes (25–30 per treatment, n = 4 replicates) were microinjected with (1) follistatin siRNA 2, (2) negative control (nonspecific) siRNA, (3) sham (water), or (4) served as uninjected controls. After injections, embryos were cultured in KSOM medium supplemented with 0.3% BSA. Proportions of embryos reaching the 2-cell stage within 30 h (early cleaving), 30–36 h (late cleaving), and within 48 h post-fertilization (total cleavage rate) were recorded. Number of embryos reaching the 8–16-cell stage was recorded 72 h after fertilization, and embryos were cultured in fresh KSOM medium supplemented with 0.3% BSA and 10% fetal bovine serum until day 7. Injection of follistatin siRNA 2 did not affect proportion of early and late cleaving embryos (21 v. 19% and 41 v. 37%) and total cleavage rate (80 v. 81%). However, injection of follistatin siRNA 2 decreased the proportion of embryos reaching the 8–16-cell stage (41 v. 59%) and percentage blastocyst development (12 v. 27%, P < 0.05). Experiments were repeated, and effects of follistatin siRNA 3 determined (25–30 embryos per treatment, n = 4 replicates). Similar results were obtained as for follistatin siRNA 2 injection. Results support a requirement of endogenous follistatin for bovine early embryogenesis.


Sign in / Sign up

Export Citation Format

Share Document